MedTrace Logo

LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis

NCT00705900 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2008-11-19

No results posted yet for this study

Summary

The purpose of this study is to compare the safety and effectiveness of a new topical LCD solution and a commercially available calcipotriol (Vitamin D) cream in reducing the symptoms of plaque psoriasis and improving the quality of life in adults.

Conditions

  • Chronic Plaque Psoriasis

Interventions

DRUG

LCD

2 applications / day for 12 weeks

DRUG

calcipotriol

2 applications / day for 12 weeks

Sponsors & Collaborators

  • NeoStrata Company, Inc.

    lead INDUSTRY

Principal Investigators

  • Alexandra B Kimball, MD · Massachusettes General Hospital / Brigham Women's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00705900 on ClinicalTrials.gov